Mannatech Announces New Tiered Affiliate Program Pre-Launch
2023年5月23日 - 9:50PM
ビジネスワイヤ(英語)
Mannatech, Incorporated (NASDAQ: MTEX), a leading
nutritional supplement company, has announced that it anticipates
launching its new tiered affiliate program on June 16, 2023. As
previously announced, the program will be operated by a new wholly
owned subsidiary doing business as Trulu™. To learn more about this
exciting opportunity, interested individuals can visit the
pre-launch website at www.incomewithoutobstacles.com.
Trulu’s flagship product, AMPM powders, contain a morning and
nighttime component formulated to support energy, mood, sleep, and
gut health in a single regimen. Trulu’s AM powder helps you feel
more motivated, focused, and energized while Trulu’s PM powder
helps you fall asleep faster, stay asleep longer, and wake up well
rested.* Both components in the AMPM regimen are built on a
foundation of prebiotics and adaptogens to optimize the efficiency
of the gut-brain axis.*
“Mannatech has been on the cutting edge of product technology
for 30 years, and Trulu is a way to innovate and capture more
market share while embracing the best attributes of the gig
economy,” said Al Bala, Mannatech’s CEO.
“We are leading with this new vision to invent a complementary
pathway to support growth in customer acquisition and retention,
revenue, profits, and value to our existing stakeholders,
shareholders, employees, and Associates,” said J. Stanley Fredrick,
Mannatech’s Chairman of the Board.
About Mannatech
Mannatech, Incorporated is committed to transforming lives
through the development of high quality integrated health, weight
management, fitness and skin care products distributed through its
global network of independent associates and members. The company
has been operating for more than 25 years with operations in 25
markets^. For more information, visit Mannatech.com.
^ Mannatech operates in China under a cross-border e-commerce
platform that is separate from its network marketing model.
*These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat,
cure, or prevent any disease.
Please Note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as
amended, and the Private Securities Litigation Reform Act of 1995.
These forward-looking statements generally can be identified by use
of phrases or terminology such as “may,” “will,” “should,” "hope,"
“could,” “would,” “expects,” “plans,” “intends,” “anticipates,”
“believes,” “estimates,” “approximates,” “predicts,” “projects,”
“potential,” and “continues” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s
objectives, strategies, plans, goals or targets contained herein
are also considered forward-looking statements. Mannatech believes
this release should be read in conjunction with all of its filings
with the United States Securities and Exchange Commission and
cautions its readers that these forward-looking statements are
subject to certain events, risks, uncertainties, and other factors.
Some of these factors include, among others, the impact of COVID-19
on Mannatech's business, Mannatech’s inability to attract and
retain associates and preferred customers, increases in
competition, litigation, regulatory changes, and its planned growth
into new international markets. Although Mannatech believes that
the expectations, statements, and assumptions reflected in these
forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement
in this release, as well as those set forth in its latest Annual
Report on Form 10-K, and other filings filed with the United States
Securities and Exchange Commission, including its current reports
on Form 8-K. All of the forward-looking statements contained herein
speak only as of the date of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230523005568/en/
Donna Giordano Manager, Executive Office Administration
972-471-6512 ir@mannatech.com www.mannatech.com
Mannatech (NASDAQ:MTEX)
過去 株価チャート
から 10 2024 まで 11 2024
Mannatech (NASDAQ:MTEX)
過去 株価チャート
から 11 2023 まで 11 2024